Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Short term Debt: 2011-2022

Historic Short term Debt for Fennec Pharmaceuticals (FENC) over the last 7 years, with Jun 2022 value amounting to $1.0 million.

  • Fennec Pharmaceuticals' Short term Debt was N/A to $1.0 million in Q2 2022 from the same period last year, while for Jun 2022 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $167.0 million for FY2017, which is 505960.61% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Short term Debt of $1.0 million as of Q2 2022, which was up 100.00% from $500,000 recorded in Q1 2022.
  • Over the past 5 years, Fennec Pharmaceuticals' Short term Debt peaked at $1.0 million during Q2 2022, and registered a low of $500,000 during Q1 2022.
  • Its 1-year average for Short term Debt is $750,000, with a median of $750,000 in 2022.